top of page
Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study
Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study
2022
Chest
Henriette Zweijpfenning SM, Chiron R, Essink S et al.; NTM-NET
DIO:
10.1016/j.chest.2022.01.015
bottom of page